Skip to Content



View full screen / Print PDF » Download PDF ⇩
Package Leaflet: Information for the User.

Powder for oral solution
For a list of active substances please see section 6.
Read all of this leaflet carefully before you start
taking this medicine.
- Keep this leaflet. You may need to read it again.
- If you have further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on
to others. It may be harmful even if their symptoms are the
same as yours.
- If any of the side effects gets serious, or if you notice any
side effects not listed in this leaflet, please tell your doctor
or pharmacist.

If you need the information on this leaflet in an alternative
format, such as large text, please ring Medical Information,
From the UK: 01895 826 606. From Ireland: 00 44 1895
826 606.
In this leaflet:
1. What MOVIPREP is and what it is used for
2. Before you take MOVIPREP
3. How to take MOVIPREP
4. Possible side effects
5. How to store MOVIPREP
6. Further information
MOVIPREP is a lemon flavoured laxative contained in four sachets.
There are two large sachets (‘Sachet A’) and two small sachets
(‘Sachet B’). You need all these for one treatment.
You are taking MOVIPREP to make your bowels clean so that they are
ready for examination.
MOVIPREP works by emptying the contents of your bowels, so you
should expect to have watery bowel movements.
Do not take MOVIPREP if you suspect or your doctor suspects:
• you are allergic (hypersensitive) to macrogol 3350 or any of the
other ingredients of MOVIPREP
• you have an obstruction in your intestine (gut).
• you have a perforated gut wall.
• you have a disorder of stomach emptying.
• you have paralysis of the gut (often occurs after an operation to
the abdomen).
• you suffer from phenylketonuria. This is an hereditary inability of
the body to use a particular amino acid. MOVIPREP contains a
source of phenylalanine.
• your body is unable to produce enough glucose-6-phosphate
• you have toxic megacolon (a severe complication of acute colitis).
Take special care with MOVIPREP
If you are in poor health or have a serious medical condition, you
should be particularly aware of the possible side effects listed in
section 4. Contact your doctor or pharmacist if you are concerned.
You should tell your doctor before taking MOVIPREP if you have any
of the following:
• you need to thicken fluids in order to swallow them safely.
• a tendency to regurgitate swallowed drink, food or acid from
the stomach.
• kidney disease.
• heart failure.
• dehydration.
• acute flare of inflammatory bowel disease (Crohn's disease or
ulcerative colitis).
MOVIPREP should not be given to patients with impaired
consciousness without medical supervision.
Taking other medicines
If you are taking other medicines take them at least one hour
before taking MOVIPREP or at least one hour afterwards
because they may be flushed through your digestive system
and not work so well.

Please tell your doctor or pharmacist if you are taking or have
recently taken any other medicines, including medicines
obtained without a prescription.
Taking MOVIPREP with food and drink
Do not take any solid food from when you start to take
MOVIPREP until after the examination.
Pregnancy and breast-feeding
There are no data on the use of MOVIPREP during pregnancy
or lactation and it should only be used if considered essential
by the physician. So if you are pregnant or breast feeding talk
to your doctor before taking MOVIPREP
Ask your doctor or pharmacist for advice before taking any
Driving and using machines
MOVIPREP does not affect your ability to drive or use machines.
Important information about some of the ingredients of
This medicinal product contains 56.2 mmol of absorbable
sodium per litre. To be taken into consideration by patients on a
controlled sodium diet.
This medicinal product contains 14.2 mmol of potassium per
litre. To be taken into consideration by patients with reduced
kidney function or patients on a controlled potassium diet.
Contains a source of phenylalanine. May be harmful for people
with phenylketonuria.
Always take MOVIPREP exactly as your doctor has told you.
You should check with your doctor or pharmacist if you are not
sure. The usual dose is 2 litres of solution, which is made up
as follows:
This pack contains 2 clear bags each containing one pair of
sachets: Sachet A and Sachet B.
Each pair of sachets (A and B) is to be dissolved in one litre of
water This pack is therefore sufficient to make up 2 litres of
MOVIPREP solution.
Before you take MOVIPREP please read carefully the following
instructions. You need to know:
• When to take MOVIPREP
• How to prepare MOVIPREP solution
• How to drink MOVIPREP
• What you should expect to happen
When to take MOVIPREP
You should have been given instructions about when to take
MOVIPREP by your doctor or nurse. Your treatment with
MOVIPREP must be completed before your clinical examination
and can be taken:
either divided as 1 litre of MOVIPREP in the evening and 1 litre
in the early morning of the day of the examination,
or 2 litres in the evening before the examination.
Important: Do not take any solid food from when you
start to take MOVIPREP until after the examination.
How to prepare MOVIPREP
• Open one clear bag and remove the sachets A and B
• Add the contents of BOTH sachet A and sachet B to a
measuring jug that holds 1 litre.
• Add water into the container up to the 1 litre mark and stir until
all the powder has dissolved and the MOVIPREP solution is
clear or slightly hazy. This may take up to 5 minutes.

How to drink MOVIPREP
Drink the first litre of the MOVIPREP solution over one to two
hours. Try to drink a glassful every 10-15 minutes.
When you are ready, make up and drink the second litre of
MOVIPREP solution made up with the contents of the sachets A
and B from the remaining bag.
During the course of this treatment, you are recommended to
drink a further one litre of clear liquid to prevent you feeling
very thirsty and becoming dehydrated. Water, clear soup, fruit
juice (without pulp), soft drinks, tea or coffee (without milk) are
all suitable. These drinks can be taken at any time you choose.
What you should expect to happen
When you start drinking the MOVIPREP solution, it is important
that you stay close to a toilet.

At some point, you will start to experience watery bowel
movements. This is quite normal and indicates that the
MOVIPREP solution is working.
The bowel movements will stop soon after you have finished
If you follow these instructions, your bowel will be clear, and
this will help you to have a successful examination.
If you take more MOVIPREP than you should
If you take more MOVIPREP than you should you may develop
excessive diarrhoea, which can lead to dehydration. Take
generous amounts of fluid, especially fruit juices. If you are
worried contact your doctor or pharmacist.
If you forget to take MOVIPREP
If you forget to take MOVIPREP take the dose as soon as you
realize you have not taken it.
If this is several hours after the time when you should have
taken it, contact your doctor or pharmacist for advice. It is
important that you complete your preparation at least an hour
before your procedure.
If you have any further questions on the use of this product,
ask you doctor or pharmacist.
MOVIPREP should not be taken by children aged
below 18 years.
Like all medicines, MOVIPREP can have side effects although
not everybody gets them.
It is normal to get diarrhoea when you take MOVIPREP
Very common side effects (i.e. affects more than 1 user in 10) are:
Abdominal pain, abdominal distension, tiredness, feeling
generally unwell, soreness of the anus, and nausea.
Common side effects (i.e. affects 1 to 10 users in 100) are:
Hunger, problems sleeping, dizziness, headache, vomiting,
indigestion, thirst and chills.
Uncommon side effects (i.e. affects 1 to 10 users in 1000) are:
discomfort, difficulties swallowing, and changes to tests of liver
The following side effects have sometimes been seen but it is
not known how often they occur because the frequency
cannot be estimated from the available data: flatulence (wind),
temporary increase in blood pressure, retching (straining to
vomit), very low blood sodium levels that can cause
convulsions (fits) and changes to the levels of salts in the blood
such as decreased bicarbonate, increased or decreased calcium,
increased or decreased chloride and decreased phosphate.
Blood potassium and sodium levels could also decrease
particularly in patients taking medicines that affect the kidney
such as ACE inhibitors and diuretics used for the treatment of
heart disease.
These reactions usually only occur for the duration of the
treatment. Should they persist, consult your doctor.
Allergic reactions may occur.
If you experience any of the following, stop your intake of
MOVIPREP and contact your doctor immediately. You should
not take any more MOVIPREP until you have checked with
your doctor.
• rash or itching
• swelling of your face, ankles or other part of your body
• palpitations
• extreme fatigue
• shortness of breath
If you do not have a bowel movement within 6 hours of taking
MOVIPREP stop the intake and contact your doctor immediately.
If any of the side effects becomes serious, or if you notice any
side effects not listed in this leaflet, please tell your doctor.
Keep out of the reach and sight of children.
Do not use MOVIPREP after the expiry date which is stated on the
carton and sachets.
The expiry date refers to the last day of the month.
Keep MOVIPREP sachets at room temperature (not above 25ºC).
After you have dissolved MOVIPREP in the water, the solution may
be stored (keeping covered) at room temperature (not above
25ºC). It may also be stored in the fridge (2ºC - 8ºC). Do not keep it
for more than 24 hours.

Medicines should not be disposed of via waste water or household
waste. Ask your pharmacist how to dispose of medicines no longer
required. These measures will help protect the environment.
Sachet A contains these active substances:
Macrogol (also known as polyethylene glycol) 3350 100 g
Sodium sulphate anhydrous
7.500 g
Sodium chloride
2.691 g
Potassium chloride
1.015 g
Sachet B contains these active substances:
Ascorbic acid
4.700 g
Sodium ascorbate
5.900 g
The concentration of electrolyte ions when both sachets are
made up to one litre of solution is as follows:
181.6 mmol/l
(of which not more than 56.2 mmol is absorbable)
59.8 mmol/l
52.8 mmol/l
14.2 mmol/l
29.8 mmol/l
Other ingredients are:
Lemon flavouring (containing maltodextrin, citral, lemon oil,
lime oil, xanthan gum, vitamin E), aspartame (E951) and
acesulfame potassium (E950) as sweeteners.
What MOVIPREP looks like and contents of the pack
This pack contains 2 clear bags each containing one pair of
sachets: Sachet A and Sachet B. Each pair of sachets (A and B)
is to be dissolved in one litre of water.
MOVIPREP powder for oral solution in sachets is available in
pack sizes of 1, 10, 40, 80, 160 and 320 packs of a single
treatment. Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder:
Norgine BV, Hogehilweg 7, 1101CA Amsterdam ZO,
The Netherlands
Norgine Limited, New Road, Hengoed, Mid Glamorgan,
CF82 8SJ, United Kingdom.
Helsinn Birex Pharmaceuticals Ltd., Damastown Mulhuddart,
Dublin 15, Ireland.
The medicinal product is authorised in the Member
States of the EEA under the following names:
Austria, Belgium, Bulgaria, Czech Republic, Denmark,
Estonia, Finland, France, Germany, Iceland, Ireland, Italy,
Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway,
Poland, Portugal, Romania, Slovakia, Slovenia, Spain and
United Kingdom: MOVIPREP
This leaflet was last approved in 07/2012
The following information is intended for medical or healthcare
professionals only.
Note for medical staff:
MOVIPREP should be administered with caution to fragile patients
in poor health or patients with serious clinical impairment such as:
• impaired gag reflex, or with a tendency to aspiration or
• impaired consciousness
• severe renal insufficiency (creatinine clearance <30 ml/min)
• cardiac impairment (NYHA grade III or IV)
• dehydration
• severe acute inflammatory disease
The presence of dehydration should be corrected before the
Semi-conscious patients or patients prone to aspiration or
regurgitation should be closely observed during administration
especially if this is via a nasogastric route.
MOVIPREP should not be given to unconscious patients.

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.